FDA Inspection
LifeCell CorporationLifeCell Corporation – FDA Inspection, Sep 21, 2026
Record Details
This FDA Inspection record concerns LifeCell Corporation, with an inspection on September 21, 2026, issued by the New Jersey District Office, covering biologics.
View Company Profile
ID · 88f4f8d7-7d1a-4e6e-b3c2-96d19d3301db
Inspection Facts
- Inspection number
- 1329332
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 1271.75(d)Donors with risks not determined ineligible
Full citation text and observation details available on the Dashboard.
Other FDA inspections of LifeCell Corporation
12| Date | Classification | Office | Project area |
|---|---|---|---|
| May 21, 2024 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 20, 2020 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 14, 2019 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
| January 10, 2019 | Not classified | New Jersey District Office | |
| September 27, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for LifeCell Corporation
- FDA Inspection 1230349 - 2024-05-21
- FDA Inspection 1120984 - 2020-02-20
- FDA Inspection 1095091 - 2019-06-14
- FDA Inspection 1089602 - 2019-01-10
- FDA Inspection 1028651 - 2017-09-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.